Cubist Pharmaceuticals

Cubist Pharmaceuticals products

C

• Cubicin® — daptomycin for injection

  • Indication: Once-daily intravenous antibiotic for serious Gram-positive infections such as MRSA bacteremia and complicated skin and skin structure infections.

D

• Dificid® — fidaxomicin

  • Indication: Treatment of Clostridioides difficile-associated diarrhea (CDAD).

E

• Entereg® — alvimopan

  • Indication: Accelerates gastrointestinal recovery following partial bowel resection surgery with primary anastomosis.

S

• Sivextro® — tedizolid phosphate

  • Indication: Treatment of acute bacterial skin and skin structure infections (ABSSSI), including MRSA.

Z

• Zerbaxa® — ceftolozane/tazobactam

• Indication: Combination antibiotic for complicated intra-abdominal infections (when paired with metronidazole) and complicated urinary tract infections.